FCGR3A and COVID-19: We found higher frequencies of neutrophils, intermediate CD14+CD16+monocytes, activated HLA-DR+CD38+, EM-like CD4+ and CD8+ T-cells in COVID-19 respiratory compared to blood samples, and similar immune responses with dexamethasone (with/without remdesivir) treatment.